|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-2-10
|
|
pubmed:abstractText |
Recent reports have showed an antiinflammatory effect of phosphodiesterase III inhibitors (PDEi) in patients undergoing cardiopulmonary bypass (CPB). We sought to evaluate the immunological and hemodynamic response to enoximone and methylprednisolone in patients undergoing CABG.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0946-1965
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
78-88
|
|
pubmed:meshHeading |
pubmed-meshheading:19203563-Anti-Inflammatory Agents,
pubmed-meshheading:19203563-Cardiopulmonary Bypass,
pubmed-meshheading:19203563-Enoximone,
pubmed-meshheading:19203563-Female,
pubmed-meshheading:19203563-Hemodynamics,
pubmed-meshheading:19203563-Hospitals, University,
pubmed-meshheading:19203563-Humans,
pubmed-meshheading:19203563-Interferon-gamma,
pubmed-meshheading:19203563-Interleukins,
pubmed-meshheading:19203563-Male,
pubmed-meshheading:19203563-Methylprednisolone,
pubmed-meshheading:19203563-Middle Aged,
pubmed-meshheading:19203563-Myocardial Revascularization,
pubmed-meshheading:19203563-Phosphodiesterase Inhibitors,
pubmed-meshheading:19203563-Postoperative Complications,
pubmed-meshheading:19203563-Prospective Studies,
pubmed-meshheading:19203563-Time Factors,
pubmed-meshheading:19203563-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Inflammatory response to cardiopulmonary bypass with enoximone or steroids in patients undergoing myocardial revascularization: a preliminary report study.
|
|
pubmed:affiliation |
Cardiac Surgery Unit, Magna Graecia University of Catanzaro, Italy.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
